Remodeling of the HDL in NIDDM: A fundamental role for cholesteryl ester transfer protein

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 6 37-6, 1998, Pages

  Castle, Christine K ^a   Kuiper, Susan L ^a   Blake, William L ^a   Paigen, Beverly ^b   Marotti, Keith R ^a   Melchior, George W ^a  

^a PFIZER INC   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Free apolipoprotein A I; High density lipoprotein lipase; KKA(y) mouse; Mouse model of non insulin dependent diabetes mellitus; Mouse plasma lipase; Pre apolipoprotein A I

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MATHEMATICAL MODEL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0031831766     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.6.e1091     Document Type: Article

References (37)

1. Agellon, L. B., A. Walsh, T. Hayek, P. Moulin, X. C. Jiang, S. A. Shelanski, J. L. Breslow, and A. R. Tall. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266: 10796-10801, 1991.
2. Asztalos, B. F., C. H. Sloop, L. Wong, and P. S. Roheim. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim. Biophys. Acta 1169: 291-300, 1993.
3. Barter, P. J., G. J. Hopkins, and Y. C. Ha. The role of lipid transfer proteins in plasma lipoprotein metabolism. Am. Heart J. 113: 538-542, 1987.
4. Belfrage, P., and M. Vaughan. Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. J. Lipid Res. 10: 341-344, 1969.
5. Berdanier, C. D. The BHE rat: an animal model for the study of non-insulin-dependent diabetes mellitus. FASEB J. 5: 2139-2144, 1991.
6. Brunzell, J. D., and A. Chait. Lipoprotein pathophysiology and treatment. In: Diabetes Mellitus. Theory and Practice (4th ed.), edited by H. Rifkin and D. Porte. New York: Elsevier, 1990, p. 756-767.
7. Castle, C. K., J. R. Colca, and G. W. Melchior. Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone. Arterioscler. Thromb. 13: 302-309, 1993.
8. Castle, C. K., M. E. Pape, K. R. Marotti, and G. W. Melchior. Secretion of pre-beta-migrating apoA-I by cynomolgus monkey hepatocytes in culture. J. Lipid Res. 32: 439-447, 1991.
9. Chajek-Shaul, T., T. Hayek, A. Walsh, and J. L. Breslow. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Proc. Natl. Acad. Sci. USA 88: 6731-6735, 1991.
10. Cheung, A. K., C. J. Parker, K. Ren, and P.-H. Iverius. Increased lipase inhibition in uremia: identification of pre-β-HDL as a major inhibitor in normal and uremic plasma. Kidney Int. 49: 1360-1371, 1996.
11. Clay, M. A., H. H. Newnham, and P. J. Barter. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler. Thromb. 11: 415-422, 1991.
12. Clay, M. A., H. H. Newnham, T. M. Forte, and P. J. Barter. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim. Biophys. Acta 1124: 52-58, 1992.
13. y mouse: a model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels 24: 297-303, 1987.
14. Gillett, M. P. T., E. M. Costa, and J. S. Owen. Evidence for active phospholipase Ain mouse plasma. Biochim. Biophys. Acta 617: 237-244, 1980.
15. Gillett, M. P. T., E. M. Vieira, and R. Dimenstein. The phospholipase activities present in preheparin mouse plasma are inhibited by antiserum to hepatic lipase. Int. J. Biochem. 25: 449-453, 1993.
16. Ginsberg, H. N. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 14: 839-855, 1991.
17. Glantz, S. A. Primer of Biostatistics. New York: McGraw-Hill, 1992.
18. Hayek, T., N. Azrolan, R. B. Verdery, A. Walsh, T. Chajek-Shaul, L. B. Agellon, A. R. Tall, and J. L. Breslow. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes and metabolism. Studies in transgenic mice. J. Clin. Invest. 92: 1143-1152, 1993.
19. Iwatsuka, H., A. Shino, and Z. Suzuoki. General survey of diabetic features of yellow KK mice. Endocrinol. Jpn. 17: 23-35, 1970.
20. Koizumi, J., A. Inazu, K. Yagi, I. Koizumi, Y. Uno, K. Kajinami, S. Miyamoto, P. Moulin, A. R. Tall, H. Mabuchi, and R. Takeda. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis 90: 189-196, 1991.
21. Koizumi, J., H. Mabuchi, A. Yoshimura, I. Michishita, M. Takeda, H. Itoh, Y. Sakai, T. Sakai, K. Ueda, and R. Takeda. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 58: 175-186, 1985.
22. Kondo, K., K. Nozawa, T. Tomita, and K. Ezaki. A strain of mouse derived from indigenous mice in Japan. Bull. Exp. Animal 6: 107-112, 1957.
23. Leiter, E. H. The genetics of diabetes susceptibility in mice. FASEB J. 3: 2231-2241, 1989.
24. Marotti, K. R., C. K. Castle, T. P. Boyle, A. H. Lin, R. W. Murray, and G. W. Melchior. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364: 73-75, 1993.
25. Marotti, K. R., C. K. Castle, R. W. Murray, E. F. Rehberg, H. G. Polites, and G. W. Melchior. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice. Arterioscler. Thromb. 12: 736-744, 1992.
26. Melchior, G. W., and C. K. Castle. Apolipoprotein A-I metabolism in cynomolgus monkey. Identification and characterization of beta-migrating pools. Arteriosclerosis 9: 470-478, 1989.
27. Melchior, G. W., C. K. Castle, R. W. Murray, W. L. Blake, D. M. Dinh, and K. R. Marotti. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels. J. Biol. Chem. 269: 8044-8051, 1994.
28. Melchior, G. W., K. A. Greenlee, C. K. Castle, M. J. Prough, R. W. Milne, K. R. Marotti, and F. J. Kézdy. Evidence that cynomolgus monkey cholesteryl ester transfer protein has two neutral lipid binding sites. J. Biol. Chem. 270: 21068-21074, 1995.
29. Melchior, G. W., and K. R. Marotti. Cholesteryl ester transfer protein's role in high density lipoprotein metabolism. Insights from studies with transgenic mice. Trends Cardiovasc. Med. 5: 83-87, 1995.
30. Nishimura, M. Breeding of mice strains for diabetes mellitus. Exp. Anim. 18: 147-157, 1969.
31. Paigen, B., P. A. Holmes, D. Mitchell, and D. Albee. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis 64: 215-221, 1987.
32. Pape, M. E., E. F. Rehberg, K. R. Marotti, and G. W. Melchior. Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein. Inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels. Arterioscler. Thromb. 11: 1759-1771, 1991.
33. Peterson, J., G. Bengtsson-Olivecrona, and T. Olivecrona. Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin. Biochim. Biophys. Acta 878: 65-70, 1986.
34. Rubin, E. M., B. Y. Ishida, S. M. Clift, and R. M. Krauss. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. USA 88: 434-438, 1991.
35. Shen, B. W., A. M. Scanu, and F. J. Kézdy. Structure of human serum lipoproteins inferred from compositional analysis. Proc. Natl. Acad. Sci. USA 74: 837-841, 1977.
36. Tall, A. R. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274, 1993.
37. Yamashita, S., D. Y. Hui, J. R. Wetterau, D. L. Sprecher, J. A. Harmony, N. Sakai, Y. Matsuzawa, and S. Tarui. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism 40: 756-763, 1991.